An optimized protocol with a stepwise approach to identify specific nuclear receptor ligands from cultured mammalian cells - Archive ouverte HAL Access content directly
Journal Articles STAR Protocols Year : 2021

An optimized protocol with a stepwise approach to identify specific nuclear receptor ligands from cultured mammalian cells

(1) , (1) , (1)
1

Abstract

Here, we describe an optimized protocol to identify specific nuclear receptor ligands. First, to rule out any compound interference with luciferase activity per se, we describe an in vitro assay assessing potential inhibition or activation of luciferase enzymatic activity. Second, to comply with EMA and FDA guidelines to mitigate drug-drug interactions, we detail assays assessing CAR and PXR activation ability. Finally, to minimize off-target detection effects, we describe the use of mammalian one-(or two-) hybrid systems. For complete details on the use and execution of this protocol, please refer to Hering et al. (2018).
Fichier principal
Vignette du fichier
Berthier et al 2021_star protocols.pdf (2.64 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-03282753 , version 1 (09-07-2021)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Alexandre Berthier, Bart Staels, Philippe Lefebvre. An optimized protocol with a stepwise approach to identify specific nuclear receptor ligands from cultured mammalian cells. STAR Protocols, 2021, 2 (3), pp.100658. ⟨10.1016/j.xpro.2021.100658⟩. ⟨inserm-03282753⟩
21 View
35 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More